APA (7th ed.) Citation

NG, N., JA, T., LW, W., J, P., E, M., TT, S., . . . RA, B. (2026). Patient-derived Organoid Pharmacotyping as a Predictive Tool for Therapeutic Selection in Pancreatic Ductal Adenocarcinoma. Annals of surgery, 283(6), e8. https://doi.org/10.1097/SLA.0000000000006517

Chicago Style (17th ed.) Citation

NG, Nicolson, et al. "Patient-derived Organoid Pharmacotyping as a Predictive Tool for Therapeutic Selection in Pancreatic Ductal Adenocarcinoma." Annals of Surgery 283, no. 6 (2026): e8. https://doi.org/10.1097/SLA.0000000000006517.

MLA (9th ed.) Citation

NG, Nicolson, et al. "Patient-derived Organoid Pharmacotyping as a Predictive Tool for Therapeutic Selection in Pancreatic Ductal Adenocarcinoma." Annals of Surgery, vol. 283, no. 6, 2026, p. e8, https://doi.org/10.1097/SLA.0000000000006517.